BB Biotech AG

    Jurisdiction
    Switzerland
    LEI
    391200MBZQNPFHIVKO34
    ISIN
    CH0038389992 (BION.SW)
    Sectors
    1. Healthcare
    2. Biotechnology

    Scores

    InsiderPie Expert Score
    52 / 100
    Even with peer group:
    51 / 100
    Fair value (Benjamin Graham formula)
    €98.51 136.8% undervalued
    Financial strength (Piotroski F-Value)
    4 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    1 / 7

    Profile

    BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. Read full profile

    Fundamentals

    Net revenue
    -€173.15M
    Gross margin
    50.2%
    EBIT
    -€202.80M
    EBIT margin
    117.1%
    Net income
    -€455.45M
    Net margin
    263.0%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    N/A €203.87M -144.8%
    N/A €209.13M +2.6%
    N/A N/A

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    Last dividend amount
    CHF 1.80
    Ex date

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    No insider transactions in the last 90 days. View older insider transactions

    Earnings Calls

    Add to watchlist

    Notifications